Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer

BACKGROUND: Although overall survival for non-small cell lung cancer (NSCLC) has increased, survival rate for pathologically staged T2aN0M0 stage IB NSCLC remains low. Adjuvant chemotherapy is not a standard treatment for stage IB NSCLC. Our purpose was to determine the efficacy of platinum-based ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seong Yong, Lee, Jin Gu, Kim, Jieun, Byun, Go Eun, Bae, Mi Kyung, Lee, Chang Young, Kim, Dae Joon, Chung, Kyung Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684513/
https://www.ncbi.nlm.nih.gov/pubmed/23759129
http://dx.doi.org/10.1186/1749-8090-8-151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684513/
https://www.ncbi.nlm.nih.gov/pubmed/23759129
http://dx.doi.org/10.1186/1749-8090-8-151

Ejemplares similares